From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection von Ridker, Paul M

Volltext

Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis von Ridker, Paul M

Volltext

Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease von Ridker, Paul M., Rane, Manas

Volltext

A Test in Context: High-Sensitivity C-Reactive Protein von Ridker, Paul M

Volltext

How Common Is Residual Inflammatory Risk? von Ridker, Paul M

Volltext

Clinician's Guide to Reducing Inflammation to Reduce Atherothrombotic Risk: JACC Review Topic of the Week von Ridker, Paul M

Volltext

From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction? von Ridker, Paul M

Volltext

Should Aspirin Be Used for Primary Prevention in the Post-Statin Era? von Ridker, Paul M

Volltext

From CANTOS to CIRT to COLCOT to Clinic: Will All Atherosclerosis Patients Soon Be Treated With Combination Lipid-Lowering and Inflammation-Inhibiting Agents? von Ridker, Paul M

Volltext

Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease: JACC Review Topic of the Week von Nelson, Kyle, Fuster, Valentin, Ridker, Paul M

Volltext

The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived von Ridker, Paul M

Volltext

LDL cholesterol: controversies and future therapeutic directions von Ridker, Paul M, Dr Prof

Volltext

Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week von Libby, Peter, Loscalzo, Joseph, Ridker, Paul M, Farkouh, Michael E, Hsue, Priscilla Y, Fuster, Valentin, Hasan, Ahmed A, Amar, Salomon

Volltext

COVID-19 – A vascular disease von Siddiqi, Hasan K., Libby, Peter, Ridker, Paul M

Volltext

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events von Ridker, Paul M, Everett, Brendan M, Pradhan, Aruna, MacFadyen, Jean G, Solomon, Daniel H, Zaharris, Elaine, Mam, Virak, Hasan, Ahmed, Rosenberg, Yves, Iturriaga, Erin, Gupta, Milan, Tsigoulis, Michelle, Verma, Subodh, Clearfield, Michael, Libby, Peter, Goldhaber, Samuel Z, Seagle, Roger, Ofori, Cyril, Saklayen, Mohammad, Butman, Samuel, Singh, Narendra, Le May, Michel, Bertrand, Olivier, Johnston, James, Paynter, Nina P, Glynn, Robert J

Volltext

Inhibiting Interleukin-6 to Reduce Cardiovascular Event Rates: A Next Step for Atherothrombosis Treatment and Prevention von Ridker, Paul M

Volltext

Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of ta... von Ridker, Paul M, MacFadyen, Jean G, Thuren, Tom, Libby, Peter

Volltext

A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians von Shim, Heejung, Chasman, Daniel I, Smith, Joshua D, Mora, Samia, Ridker, Paul M, Nickerson, Deborah A, Krauss, Ronald M, Stephens, Matthew

Volltext

C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: Moving an inflammatory hypothesis toward consensus von RIDKER, Paul M

Volltext

Targeting residual inflammatory risk: The next frontier for atherosclerosis treatment and prevention von Ridker, Paul M

Volltext